In the era of "channel is king", the more terminals pharmaceutical distribution companies have, the more complete the channel network, the greater its role in the value transfer link, the greater the right to speak, the production enterprises to cover more retail terminals are the first to compete for the channel business pharmaceutical distribution companies. "Chain" and "Internet" is the two major inevitable trends of the pharmaceutical retail terminal, on the one hand, the distribution of single retail terminals around the country gradually by such as "the people's pharmacy", "Yifeng Pharmacy", Neptune Star and other regional or national pharmaceutical chain merger, once the trend of chaining into a new circulation pattern, the production enterprises will split the pharmaceutical distribution enterprises directly to the pharmaceutical chain, this is an efficiency enhancement, will greatly reduce the intermediate links, improve efficiency, channel cost savings, but also to achieve Terminal wide coverage of the purpose, at this time as a channel intermediary of the advantages of the pharmaceutical distribution enterprises will be greatly weakened. And the more subversive Internet drug retail model, in addition to the impact on the original traditional retail industry, its business model does not require the participation of traditional pharmaceutical distribution enterprises, its direct face to the consumer, to complete the information flow, capital flow and logistics and distribution and other value transfer links, subversive enhancement of the efficiency of the traditional information flow, capital flow and logistics. In the pharmaceutical Internet retail model, the traditional pharmaceutical distribution enterprises even participate in the "value transfer" qualification is no longer, how to exist value.
The second, "medicine control sales" new model weakened the traditional pharmaceutical distribution enterprises in the "transfer of value" link.
We do not discuss the last two years in the field of medicine prevailing "medicine control sales model" can go far, but this new model in its development over the years to the traditional medicine circulation enterprises to a heavy blow, the emergence of this model, so that a large number of pharmaceutical circulation enterprises into "over the ticket "The company, pharmaceutical controlled sales model of "funds" by the first-line agents, "logistics and distribution" by the first-line agents to solve their own problems, "market expansion" By the pharmaceutical agent to do, "product sales" by the first-line agent is responsible for. Pharmaceutical distribution enterprises in the easy, fast earn "over the ticket" to bring income at the same time gradually lost its value to the production enterprise ---- for the enterprise to provide capital flow, for the enterprise to the terminal to pass enterprise-level product information, for the enterprise to provide terminal network coverage and logistics distribution. Production enterprises found that the previous kind of marketing approach of using channel distribution wide coverage is no longer effective, more production enterprises gradually give up the original "channel strategy" to layout the "pharmaceutical control sales model" is a strong illustration, at this time, the traditional pharmaceutical distribution enterprise's The value of the traditional pharmaceutical distribution enterprises was weakened again, was abandoned by the upstream production enterprises, because the new market environment, the traditional pharmaceutical distribution enterprises can not bring value to the upstream production enterprises, was abandoned is "inevitable". From this point of view, where is the future of our traditional enterprises?
Three, the rise of the pharmaceutical Internet B2B enterprises on the subversive impact of the traditional pharmaceutical distribution enterprises
B2B (also written as BTB, is the abbreviation of Business-to-Business) refers to the business-to-business business relationship, through the B2B website and the customer is closely integrated through the network of rapid response to provide customers with a better services, thus facilitating business development. Again, it is emphasized that the Internet brings about the elimination of distance (intermediaries), enhances efficiency, and is a revolutionary liberation of communication efficiency. Pharmaceutical B2B enterprises that is the use of Internet technology to transform the traditional circulation links, improve efficiency, reduce circulation costs, its emergence and maturity model will have a disruptive impact on the traditional distribution of wholesale enterprises. Pharmaceutical B2B is not just appeared, the Internet giant Alibaba's Ali Health, which in the pharmaceutical B2C license and then obtained the pharmaceutical Internet A certificate, after obtaining the A certificate, it has a direct participation in the wholesale business of medicine, Ali Health's flow, technology, and logistics and other advantages will be directly transformed to optimize the traditional circulation of information flow, capital flow and logistics and other aspects of the traditional circulation of the enterprise will have a direct impact, another Internet giant. Direct impact, another Internet giant Jingdong also recently broke the news in the active layout of the pharmaceutical B2B market. In addition, medicine online, business Kang medicine, drug terminal network and the pharmaceutical industry familiar large-scale pharmaceutical distribution enterprises, such as jiuzhou pass has long been the layout of the pharmaceutical B2B business for many years, these companies use their different advantages in the transformation and upgrading of the traditional pharmaceutical circulation, once the layout of the mature, the advantages of its quite obvious, will be on the traditional pharmaceutical distribution enterprises to produce a direct and subversive impact.
Four, the entry of express logistics enterprises and Internet + logistics on the traditional pharmaceutical distribution enterprise logistics value
Traditional pharmaceutical distribution enterprises in the transfer of business value is an important value of logistics, the upstream production enterprises for the continuous delivery of products to the pharmaceutical retail terminal, which is the value of the traditional pharmaceutical logistics is characterized by the main pieces of bulk logistics, the development of information technology and the pharmaceutical Internet retail business. With the development of information technology and the development of pharmaceutical Internet retail industry, pharmaceutical logistics and distribution have higher requirements, and China's logistics giant SF has long been pharmaceutical logistics license, set up SF Food and Drug Logistics Division layout of pharmaceutical logistics, pharmaceutical logistics than other industries logistics has its own particularity, and SF as a nationwide logistics giant, in its access to pharmaceutical logistics distribution qualification of its logistics network, vehicles, efficiency and price. In terms of logistics network, vehicles, efficiency and price has obvious advantages, another "Internet + medicine logistics" on the transformation of the traditional medicine circulation link will also directly affect the original medicine circulation enterprise logistics business. To shunfeng medicine logistics and other amateur intervention and "internet + logistics" transformation and upgrading of our traditional medicine circulation enterprise logistics value impact. Then the traditional pharmaceutical distribution enterprises of the original logistics network and distribution advantages and will be more efficient, lower cost of professional logistics enterprises to replace, and thus affect its survival and development.
The traditional pharmaceutical distribution enterprises to face the challenge is far more than the above four aspects. In the face of new trends, new environments, we should change our thinking, reduce dependence on the existing successful path, actively embrace change and rapid internal change and upgrading transformation.